このアイテムのアクセス数: 287

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
2643-3230.BCD-21-0044.pdf8.24 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorKoya, Junjien
dc.contributor.authorSaito, Yukien
dc.contributor.authorKameda, Takuroen
dc.contributor.authorKogure, Yasunorien
dc.contributor.authorYuasa, Mitsuhiroen
dc.contributor.authorNagasaki, Jojien
dc.contributor.authorMcClure, Marni B.en
dc.contributor.authorShingaki, Sumitoen
dc.contributor.authorTabata, Marikoen
dc.contributor.authorTahira, Yukien
dc.contributor.authorAkizuki, Keiichien
dc.contributor.authorKamiunten, Ayakoen
dc.contributor.authorSekine, Masaakien
dc.contributor.authorShide, Kotaroen
dc.contributor.authorKubuki, Yokoen
dc.contributor.authorHidaka, Tomonorien
dc.contributor.authorKitanaka, Akiraen
dc.contributor.authorNakano, Nobuakien
dc.contributor.authorUtsunomiya, Ataeen
dc.contributor.authorTogashi, Yosukeen
dc.contributor.authorOgawa, Seishien
dc.contributor.authorShimoda, Kazuyaen
dc.contributor.authorKataoka, Keisukeen
dc.contributor.alternative古屋, 淳史ja
dc.contributor.alternative斎藤, 優樹ja
dc.contributor.alternative亀田, 拓郎ja
dc.contributor.alternative木暮, 泰寛ja
dc.contributor.alternative湯浅, 光博ja
dc.contributor.alternative長崎, 譲慈ja
dc.contributor.alternative新垣, 清登ja
dc.contributor.alternative田畑, 真梨子ja
dc.contributor.alternative田平, 優貴ja
dc.contributor.alternative秋月, 渓一ja
dc.contributor.alternative上運天, 綾子ja
dc.contributor.alternative関根, 雅明ja
dc.contributor.alternative幣, 光太郎ja
dc.contributor.alternative久冨木, 庸子ja
dc.contributor.alternative日高, 智徳ja
dc.contributor.alternative北中, 明ja
dc.contributor.alternative中野, 伸亮ja
dc.contributor.alternative宇都宮, 與ja
dc.contributor.alternative冨樫, 庸介ja
dc.contributor.alternative小川, 誠司ja
dc.contributor.alternative下田, 和哉ja
dc.contributor.alternative片岡, 圭亮ja
dc.date.accessioned2021-09-09T02:38:47Z-
dc.date.available2021-09-09T02:38:47Z-
dc.date.issued2021-09-
dc.identifier.urihttp://hdl.handle.net/2433/265164-
dc.description成人T細胞白血病リンパ腫の多段階発がん分子メカニズムを解明 --難治性疾患の新規治療標的候補を複数同定--. 京都大学プレスリリース. 2021-09-07.ja
dc.description.abstractPremalignant clonal expansion of human T-cell leukemia virus type-1 (HTLV-1)–infected cells occurs before viral carcinogenesis. Here we characterize premalignant cells and the multicellular ecosystem in HTLV-1 infection with and without adult T-cell leukemia/lymphoma (ATL) by genome sequencing and single-cell simultaneous transcriptome and T/B-cell receptor sequencing with surface protein analysis. We distinguish malignant phenotypes caused by HTLV-1 infection and leukemogenesis and dissect clonal evolution of malignant cells with different clinical behavior. Within HTLV-1–infected cells, a regulatory T-cell phenotype associates with premalignant clonal expansion. We also delineate differences between virus- and tumor-related changes in the nonmalignant hematopoietic pool, including tumor-specific myeloid propagation. In a newly generated conditional knockout mouse model recapitulating T-cell–restricted CD274 (encoding PD-L1) gene lesions found in ATL, we demonstrate that PD-L1 overexpressed by T cells is transferred to surrounding cells, leading to their PD-L1 upregulation. Our findings provide insights into clonal evolution and immune landscape of multistep virus carcinogenesis.en
dc.language.isoeng-
dc.publisherAmerican Association for Cancer Research (AACR)en
dc.rights©2021 The Authors; Published by the American Association for Cancer Researchen
dc.rightsThis open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 International (CC BY-NC-ND).en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleSingle-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1en
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleBlood Cancer Discoveryen
dc.identifier.volume2-
dc.identifier.issue5-
dc.identifier.spage450-
dc.identifier.epage467-
dc.relation.doi10.1158/2643-3230.BCD-21-0044-
dc.textversionpublisher-
dc.addressDivision of Molecular Oncology, National Cancer Center Research Instituteen
dc.addressDivision of Molecular Oncology, National Cancer Center Research Institute; Department of Gastroenterology, Keio University School of Medicineen
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDivision of Molecular Oncology, National Cancer Center Research Instituteen
dc.addressDivision of Molecular Oncology, National Cancer Center Research Institute; Department of Pathology, Graduate School of Medicine, The University of Tokyoen
dc.addressChiba Cancer Center, Research Instituteen
dc.addressDivision of Molecular Oncology, National Cancer Center Research Instituteen
dc.addressDivision of Molecular Oncology, National Cancer Center Research Instituteen
dc.addressDivision of Molecular Oncology, National Cancer Center Research Institute; Department of Urology, Graduate School of Medicine, The University of Tokyoen
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDepartment of Laboratory Medicine, Kawasaki Medical Schoolen
dc.addressDepartment of Hematology, Imamura General Hospitalen
dc.addressDepartment of Hematology, Imamura General Hospitalen
dc.addressChiba Cancer Center, Research Instituteen
dc.addressDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto Universityen
dc.addressDivision of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazakien
dc.addressDivision of Molecular Oncology, National Cancer Center Research Institute; Division of Hematology, Department of Medicine, Keio University School of Medicineen
dc.identifier.pmid34661162-
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2021-09-07-
dcterms.accessRightsopen access-
datacite.awardNumber19K22573-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19K22573/-
dc.identifier.pissn2643-3230-
dc.identifier.eissn2643-3249-
jpcoar.funderName日本学術振興会ja
jpcoar.awardTitle新規単一細胞解析技術を用いたがん免疫微小環境の解明ja
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons